A Prospective, Randomized, Controlled, Multicenter Trial of Chinese Herbs by Stages Combined with Chemotherapy for Advanced Non-Small Cell Lung Cancer
Z. Xu,C. Jin,Z. Wang,H. Deng,D. Shen,M. Zhang,M. Li,J. Wang,Z. Zheng,Y. Gong
DOI: https://doi.org/10.1200/jco.2010.28.15_suppl.e18000
IF: 45.3
2010-01-01
Journal of Clinical Oncology
Abstract:e18000 Background: Chemotherapy plays an important role in the treatment of advanced non-small cell lung cancer (NSCLC), but the overall survival (OS) and the median survival time (MST) are not satisfactory. Chinese herbs (CH) is a popular treatment for NSCLC in china. Our purpose was to observe the efficacy of CH by stages combined with chemotherapy versus chemotherapy alone for NSCLC (stage III/IV). Methods: A prospective, randomized, controlled, multicenter, clinical trial was conducted on 115 patients assigned to treatment group (60) and control group (55). The control group was treated by chemotherapy (cisplatin and gemcitabine [GP]/cisplatin and vinorelbine [NP]) alone, while the treatment group was treated by chemotherapy (GP/NP) combined with CH and was administered Kangliuzengxiao decoction (KLZX) during chemotherapy course and Feiyanning decoction (FYN) maintenance after chemotherapy. End points were OS, MST, response rate, toxicity, and Karnofsky score. Results: MST was 14.47 months (95% confidence interval, 10.37 to 18.57) in treatment group compared with 10.97 months (95% confidence interval, 9.35 to 12.59) in control group (p = 0.001). 1 year, 2 years, 3 years, 5 years survival rates in treatment group were 54.8%, 24.6%, 13.2%, 5.7%, compared to control group 35.6%, 3.7%, 0%, 0% (p = 0.001). The response rates (CR+PR) were 28.3% (treatment group) and 18.2% (control group), there was no statistically significant difference in response rate between the two groups. The toxicities mainly were gastrointestinal dysfunction and myelosuppression of different degrees. Remission rate of nausea/vomiting symptoms was high after patients treated with CH in treatment group (p < 0.05), myelosuppression was more significant in control group than in treatment group (p < 0.05). Karnofsky score of treatment group was higher than that of control group (p < 0.01) (p < 0.01). Conclusions: In this trial, chinese herbs by stages combined with chemotherapy could prolong the MST and OS,still improve Karnofsky score, while the toxicity was not enhanced. Chinese herbal medicine was a promising maintenance treatment for advanced NSCLC. No significant financial relationships to disclose.